Recipharm, a contract development and manufacturing organization, is currently in discussions with Alcon, the eye-care business of Novartis, and has reached agreement in principle to enter into a long-term manufacturing agreement for a range of ophthalmology products. As part of this arrangement, Recipharm will also acquire Alcon's manufacturing facility located in Kaysersberg, France.

The 260 people currently employed at the Kaysersberg site would transfer and continue to be offered employment by Recipharm following the date of the sale. Further details will be made available following the end of consultation with the Works Council of Alcon and finalization of the negotiations.

Recipharm has facilities in Sweden, France, the UK, Germany, Spain, Italy and Portugal and is headquartered in Jordbro, Sweden.

Source: Recipharm